SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-105836
Filing Date
2013-03-14
Accepted
2013-03-13 21:45:07
Documents
2
Period of Report
2013-03-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d502288d8k.htm 8-K 18518
2 EXHIBIT 10.1 d502288dex101.htm EX-10.1 169776
  Complete submission text file 0001193125-13-105836.txt   189619
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52228 | Film No.: 13688950
SIC: 8731 Services-Commercial Physical & Biological Research